1.4642
전일 마감가:
$1.49
열려 있는:
$1.51
하루 거래량:
18,587
Relative Volume:
0.24
시가총액:
$11.23M
수익:
$598.00K
순이익/손실:
$-44.93M
주가수익비율:
-0.1762
EPS:
-8.31
순현금흐름:
$-17.32M
1주 성능:
-5.81%
1개월 성능:
-25.13%
6개월 성능:
-65.94%
1년 성능:
-94.57%
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
명칭
Ernexa Therapeutics Inc
전화
(617) 798-6700
주소
1035 CAMBRIDGE STREET, CAMBRIDGE
ERNA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ERNA
Ernexa Therapeutics Inc
|
1.4642 | 10.55M | 598.00K | -44.93M | -17.32M | -8.31 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
390.01 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
587.47 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
451.39 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
704.43 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
298.43 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc 주식(ERNA)의 최신 뉴스
Will Ernexa Therapeutics Inc. see short term momentumJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
What does recent volatility data suggest for Ernexa Therapeutics Inc.July 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser
Ernexa Therapeutics Inc. stock trend outlook and recovery pathQuarterly Profit Report & AI Powered Market Trend Analysis - Newser
Ernexa Therapeutics Inc. stock outlook for YEARMarket Activity Report & AI Driven Stock Reports - Newser
Detecting price anomalies in Ernexa Therapeutics Inc. with AI2025 Price Action Summary & Weekly Consistent Profit Watchlists - Newser
What moving averages say about Ernexa Therapeutics Inc.Breakout Watch & Capital Efficient Trade Techniques - Newser
What’s next for Ernexa Therapeutics Inc. stock priceJuly 2025 Highlights & Daily Stock Trend Watchlist - Newser
Using economic indicators to assess Ernexa Therapeutics Inc. potentialTrade Volume Report & Technical Entry and Exit Tips - Newser
Is Ernexa Therapeutics Inc. forming a bottoming basePortfolio Performance Report & Safe Capital Growth Plans - Newser
Long term hold vs stop loss in Ernexa Therapeutics Inc.July 2025 Intraday Action & Growth Oriented Trade Recommendations - Newser
Price action breakdown for Ernexa Therapeutics Inc.Quarterly Trade Review & Reliable Breakout Forecasts - Newser
Analyzing recovery setups for Ernexa Therapeutics Inc. investors2025 Market Outlook & Stepwise Entry and Exit Trade Signals - Newser
Has Ernexa Therapeutics Inc. found a price floor2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Forecasting Ernexa Therapeutics Inc. price range with options dataDividend Hike & Stepwise Swing Trade Plans - Newser
Price action breakdown for Ernexa Therapeutics Inc2025 Market Sentiment & Free Safe Entry Trade Signal Reports - Newser
How institutional ownership impacts Ernexa Therapeutics Inc. stockIPO Watch & Target Return Focused Picks - Newser
Market Fear: How is Ernexa Therapeutics Inc. managing supply chain issuesJuly 2025 PreEarnings & Smart Money Movement Alerts - theviewers.co.kr
Full technical analysis of Ernexa Therapeutics Inc. stock2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
Is Ernexa Therapeutics Inc. vulnerable to short sellersJuly 2025 Movers & Fast Gain Stock Trading Tips - theviewers.co.kr
Is This a Bottoming Phase for Ernexa Therapeutics Inc.Watch List & Growth-Oriented Investment Plans - beatles.ru
Screener Results Flag Ernexa Therapeutics Inc. as OversoldInsider Buying & Community Shared Stock Ideas - newsyoung.net
Will Ernexa Therapeutics Inc. stock benefit from AI tech trends2025 Market Outlook & Growth Oriented Trading Recommendations - beatles.ru
What are the future prospects of Ernexa Therapeutics Inc.Portfolio Performance Summary & Pattern Based Trade Signal System - 선데이타임즈
Real time breakdown of Ernexa Therapeutics Inc. stock performanceQuarterly Performance Summary & Daily Market Momentum Tracking - Newser
Should you hold or exit Ernexa Therapeutics Inc. nowCEO Change & AI Forecasted Entry/Exit Points - Newser
Ernexa Therapeutics Inc (ERNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ernexa Therapeutics Inc 주식 (ERNA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
자본화:
|
볼륨(24시간):